cyproterone acetate has been researched along with diethylstilbestrol in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (53.70) | 18.7374 |
| 1990's | 18 (33.33) | 18.2507 |
| 2000's | 5 (9.26) | 29.6817 |
| 2010's | 2 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kastelan, M; Kraljić, I; Tarle, M | 1 |
| Mukamel, E; Nussbaum, B; Servadio, C | 1 |
| Bläuer, MK; Joensuu, TK; Sannisto, T; Tuohimaa, PJ | 1 |
| Radoś, N; Tarle, M | 1 |
| Becker, M; Goldschmidt, AJ; Peter, K; Tunn, UW | 1 |
| Moffat, LE | 1 |
| de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S; Sylvester, R | 1 |
| Schaison, G | 1 |
| Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Schröder, FH; Smith, PH; Suciu, S; Sylvester, R; Viggiano, G | 1 |
| Milsted, RA | 1 |
| Varenhorst, E; Wallentin, L | 1 |
| Licea Puig, M; Más Díaz, J; Padrón Durán, RS | 1 |
| de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S | 2 |
| Baulieu, EE; Jung-Testas, I | 1 |
| Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G | 1 |
| Fair, WR | 1 |
| Amselgruber, W; Hartmann, RW; Schneider, MR; Sinowatz, F | 1 |
| Alexandre, C; Balthazart, J | 1 |
| Barasolo, E; De Pauw, M; de Voogt, H; Ingargiola, GB; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G | 1 |
| Robinson, MR | 4 |
| Bruchovsky, N; Fletcher, T; Foekens, JA; Goldenberg, SL; Lawson, D; Rennie, PS | 1 |
| Debruyne, FM | 1 |
| Ferro, MA; Heinemann, D; Smith, PJ; Symes, MO | 1 |
| Bruchovsky, N; Coppin, CM; Goldenberg, SL; Rennie, PS | 1 |
| deVoogt, HJ; Pavone-Macaluso, M; Schröder, FH; Sylvester, R | 1 |
| Bollack, C; Rougeron, G | 1 |
| Pachman, A | 1 |
| Isaacs, JT | 1 |
| Schroeder, FH | 1 |
| Büller, HR; Dabhoiwala, NF; Henny, CP; ten Cate, H; ten Cate, JW | 1 |
| Allen, JM; Bloom, SR; Kerle, D; O'Shea, JP; Smith, C; Williams, G; Yeo, T | 1 |
| Bruchovsky, N; Gleave, ME; Goldenberg, SL; Jones, EC; Sullivan, LD | 1 |
| Cooper, EH; Purves, D; Whelan, P | 1 |
| Akakura, K; Bruchovsky, N; Gleave, ME; Goldenberg, SL; Sullivan, LD | 1 |
| Akakura, K; Bruchovsky, N; Buckley, AR; Goldenberg, SL; Rennie, PS; Sullivan, LD | 1 |
| Akakura, K; Bruchovsky, N; Goldenberg, SL; Rennie, PS | 1 |
| Kasson, BG; Li, YD | 1 |
| McLeod, DG | 1 |
| Denis, L | 2 |
| de Pauw, M; Newling, DW; Richards, B; Robinson, MR; Smith, PH; Sylvester, R | 1 |
| Bruchovsky, N; Gleave, ME; Goldenberg, SL; Sullivan, LD | 1 |
| Bruchovsky, N; Gleave, ME; Goldenberg, SL; Jones, EC; La Bianca, SE; Sullivan, LD | 1 |
| Gupta, C | 1 |
| Assinder, SJ; Nicholson, HD | 1 |
| Berthelet, E; Lee, KW; Liu, M; Pickles, T; Truong, PT | 1 |
| Bastide, C; Bruyère, F; Guy, L; Karsenty, G; Rozet, F | 1 |
5 review(s) available for cyproterone acetate and diethylstilbestrol
| Article | Year |
|---|---|
Initiation of LHRH monotherapy for prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Neoplasms | 1989 |
Is there a best endocrine management of prostatic carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Castration; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
Antiandrogenic drugs.
Topics: Androgen Receptor Antagonists; Anilides; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Megestrol; Megestrol Acetate; Nitriles; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds | 1993 |
Prostate cancer. Primary hormonal treatment.
Topics: Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Estrogens; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Orchiectomy; Patient Participation; Prostate; Prostatic Neoplasms; Receptors, Androgen; Testosterone | 1993 |
[Hormonal treatment in prostate cancer].
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Benzamides; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Estrogens, Non-Steroidal; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatectomy; Prostatic Neoplasms | 2013 |
20 trial(s) available for cyproterone acetate and diethylstilbestrol
| Article | Year |
|---|---|
Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Topics: Androgen Antagonists; Breast; Buserelin; Cardiovascular Diseases; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Goserelin; Humans; Male; Prospective Studies; Prostatic Neoplasms | 1990 |
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
Topics: Adult; Aged; Aged, 80 and over; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Nitrogen Mustard Compounds; Prognosis; Prospective Studies; Prostatic Neoplasms; Random Allocation; Statistics as Topic | 1989 |
EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group
Topics: Androgen Antagonists; Antineoplastic Agents; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Prostatic Neoplasms; Random Allocation | 1989 |
Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer tria
Topics: Aged; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation; Time Factors | 1986 |
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological
Topics: Aged; Bone Neoplasms; Carcinoma; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms; Random Allocation | 1986 |
Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
Topics: Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1987 |
Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
Topics: Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms | 1987 |
EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
Topics: Adenocarcinoma; Clinical Protocols; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Humans; Male; Orchiectomy; Prostatic Neoplasms | 1988 |
Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
Topics: Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Random Allocation | 1988 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
Is there a best endocrine management of prostatic carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Castration; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
Re: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Heart; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
Treatment of prostatic cancer: the EORTC experience--preliminary results of prostatic carcinoma trials.
Topics: Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Procarbazine; Prostatic Neoplasms; Random Allocation; Vinblastine; Vindesine | 1984 |
Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyproterone Acetate; Diethylstilbestrol; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Testosterone; Time Factors | 1996 |
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Diethylstilbestrol; Drug Therapy, Combination; Follow-Up Studies; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Time Factors | 1995 |
Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Pituitary Gland; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Survival Rate; Testosterone | 1993 |
A further analysis of European Organization for Research and Treatment of Cancer protocol 30805. Orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose diethylstilbestrol.
Topics: Antineoplastic Agents; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Follow-Up Studies; Humans; Male; Orchiectomy; Prostatic Neoplasms; Survival Rate | 1993 |
The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of t
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Humans; Male; Orchiectomy; Prostatic Neoplasms; Survival Rate; Time Factors | 1995 |
Low-dose cyproterone acetate plus mini-dose diethylstilbestrol--a protocol for reversible medical castration.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Clinical Protocols; Confidence Intervals; Cyproterone Acetate; Diethylstilbestrol; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Testosterone | 1996 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
30 other study(ies) available for cyproterone acetate and diethylstilbestrol
| Article | Year |
|---|---|
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: hormone regulatory effects in vivo.
Topics: Acid Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Cyproterone Acetate; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Diethylstilbestrol; Estradiol; Estramustine; Flutamide; Hormones; Humans; Hydrocortisone; Killer Cells, Natural; Male; Orchiectomy; Prolactin; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 1992 |
Fifteen years' experience of combined hormone/chemotherapy in metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Retrospective Studies | 1992 |
The effect of dihydrotestosterone on the estrogen-induced cytodifferentiation of the chick oviduct.
Topics: Androgen Antagonists; Animals; Cell Differentiation; Chickens; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Female; Immunohistochemistry; Male; Oviducts; Progesterone; Prostate; Receptors, Androgen; Skin; Skin Physiological Phenomena | 1992 |
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Topics: Acid Phosphatase; Antigens, Neoplasm; Antineoplastic Agents; APUD Cells; Biomarkers, Tumor; Carcinoembryonic Antigen; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Flutamide; Humans; Male; Orchiectomy; Phosphopyruvate Hydratase; Prostate-Specific Antigen; Prostatic Neoplasms | 1991 |
Initial treatment of prostatic cancer by endocrine measures and cytotoxic drugs.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Fluorouracil; Humans; Male; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms; Survival Rate | 1990 |
Management of metastatic prostatic carcinoma.
Topics: Adrenalectomy; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Ketoconazole; Male; Orchiectomy; Palliative Care; Prostatic Neoplasms | 1986 |
[Treatment of cancer of the prostate. New hormonal approaches].
Topics: Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Male; Orchiectomy; Prostatic Neoplasms; Testosterone | 1989 |
Re: The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
Topics: Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Therapy, Combination; Humans; Male; Prostatic Neoplasms | 1989 |
[Evaluation of cyproterone acetate in the treatment of hirsutism].
Topics: Androgens; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Evaluation; Drug Therapy, Combination; Female; Hirsutism; Humans; Menstruation Disturbances | 1985 |
Effects of steroid hormones and antihormones in cultured cells.
Topics: Animals; Cell Division; Cells, Cultured; Cyproterone; Cyproterone Acetate; Dexamethasone; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Estrenes; Glucocorticoids; Gonadal Steroid Hormones; L Cells; Mammary Neoplasms, Experimental; Mice; Mifepristone; Receptors, Androgen; Receptors, Estrogen; Receptors, Glucocorticoid; Tamoxifen; Thymoma | 1985 |
Hormonal therapy of advanced prostatic cancer.
Topics: Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1986 |
Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity.
Topics: Animals; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estradiol; Estrogen Antagonists; Estrogens; Genitalia, Male; Male; Mice; Organ Size; Progesterone; Prostatic Neoplasms; Rats; Stilbenes; Tamoxifen; Testosterone | 1986 |
Effects of metabolism inhibitors, antiestrogens and antiandrogens on the androgen and estrogen induced sexual behavior in Japanese quail.
Topics: Androgens; Androstatrienes; Animals; Coturnix; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estrogens; Flutamide; Male; Orchiectomy; Quail; Sexual Behavior, Animal; Tamoxifen; Testosterone | 1986 |
Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
Topics: Anilides; Animals; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Flutamide; Gonadotropin-Releasing Hormone; Imidazoles; Imidazolidines; Leuprolide; Male; Megestrol; Megestrol Acetate; Orchiectomy; Prostate; Rats; Rats, Inbred Strains; Receptors, Androgen | 1988 |
Effect of stilboestrol and testosterone on the incorporation of 75selenomethionine by prostatic carcinoma cells.
Topics: Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estradiol; Humans; Male; Neoplasm Proteins; Prostatic Neoplasms; Selenomethionine; Testosterone; Tumor Cells, Cultured | 1988 |
The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Evaluation; Drug Synergism; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Pilot Projects; Prostatic Neoplasms; Testosterone | 1988 |
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
Topics: Androgen Antagonists; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1988 |
Studies on the role of the sex-hormone-binding globulin (SHBG) in prostatic gland hypertrophy in men. II. In vitro research.
Topics: Adult; Cell Nucleus; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Female; Humans; Male; Pregnancy; Prostate; Prostatic Hyperplasia; Sex Hormone-Binding Globulin; Testosterone | 1984 |
Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.
Topics: Adenocarcinoma; Animals; Castration; Cell Division; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Kinetics; Male; Neoplasms, Experimental; Prostatic Neoplasms; Rats | 1982 |
Effect of hormonal manipulation on antithrombin III activity in patients with prostatic carcinoma.
Topics: Aged; Antithrombin III; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Fibrinolysis; Humans; Male; Middle Aged; Prostatic Neoplasms | 1984 |
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Topics: Adenocarcinoma; Buserelin; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1984 |
Bone alkaline phosphatase and prostate-specific antigen in the monitoring of prostate cancer.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Cyproterone Acetate; Diethylstilbestrol; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Isoenzymes; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Staging; Orchiectomy; Probability; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Time Factors | 1994 |
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Cyproterone Acetate; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasm Staging; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1993 |
Androgens augment vasoactive intestinal peptide- and growth hormone-releasing hormone-stimulated progestin production by rat granulosa cells.
Topics: 20-alpha-Dihydroprogesterone; Androgens; Animals; Cells, Cultured; Cyproterone Acetate; Diethylstilbestrol; Drug Synergism; Female; Granulosa Cells; Growth Hormone-Releasing Hormone; Hydrocortisone; Kinetics; Metribolone; Progesterone; Promegestone; Rats; Rats, Sprague-Dawley; Vasoactive Intestinal Peptide | 1993 |
Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Drug Therapy, Combination; Flutamide; Follow-Up Studies; Humans; Leuprolide; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Recurrence; Treatment Outcome | 2000 |
The role of estrogen receptor, androgen receptor and growth factors in diethylstilbestrol-induced programming of prostate differentiation.
Topics: Androgen Antagonists; Animals; Antibodies; Cyproterone Acetate; Diethylstilbestrol; Embryonic and Fetal Development; Epidermal Growth Factor; Estrogen Receptor Modulators; Estrogens, Non-Steroidal; Flutamide; Growth Substances; Male; Organ Culture Techniques; Prostate; Receptors, Androgen; Receptors, Estrogen; Sex Differentiation | 2000 |
Effects of steroids on oxytocin secretion by the human prostate in vitro.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androgens; Animals; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Humans; In Vitro Techniques; Male; Middle Aged; Oxytocin; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Rats; Testosterone; Time Factors | 2004 |
Long-term androgen deprivation therapy improves survival in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/mL.
Topics: Aged; Analysis of Variance; Androgen Antagonists; Cyproterone Acetate; Diethylstilbestrol; Humans; Male; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Regression Analysis; Survival Rate; Time Factors | 2005 |